[Back to Issue 3 ToC] [Back to Journal Contents] [Back to Biochemistry (Moscow) Home page]

Novel Gain-of-Function Mutation in the Kv11.1 Channel Found in the Patient with Brugada Syndrome and Mild QTc Shortening


Denis Abramochkin1,2,a, Bowen Li1,b, Han Zhang1,c, Ekaterina Kravchuk2,d, Tatiana Nesterova3,4,e, Grigory Glukhov1,2,f, Anna Shestak5,g, Elena Zaklyazminskaya5,h, and Olga S. Sokolova1,2,i*

1Shenzhen MSU-BIT University, Shenzhen, China

2Lomonosov Moscow State University, 119234, Moscow, Russia

3Institute of Immunology and Physiology, Ural Branch of Russian Academy of Sciences, 620049 Ekaterinburg, Russia

4Institute of Natural Sciences and Mathematics, Ural Federal University, 620075 Ekaterinburg, Russia

5Petrovsky National Research Center of Surgery, 119991 Moscow, Russia

Received December 6, 2023; Revised February 20, 2024; Accepted February 27, 2024
Brugada syndrome (BrS) is an inherited disease characterized by right precordial ST-segment elevation in the right precordial leads on electrocardiograms (ECG), and high risk of life-threatening ventricular arrhythmia and sudden cardiac death (SCD). Mutations in the responsible genes have not been fully characterized in the BrS patients, except for the SCN5A gene. We identified a new genetic variant, c.1189C>T (p.R397C), in the KCNH2 gene in the asymptomatic male proband diagnosed with BrS and mild QTc shortening. We hypothesize that this variant could alter IKr-current and may be causative for the rare non-SCN5A-related form of BrS. To assess its pathogenicity, we performed patch-clamp analysis on IKr reconstituted with this KCNH2 mutation in the Chinese hamster ovary cells and compared the phenotype with the wild type. It appeared that the R397C mutation does not affect the IKr density, but facilitates activation, hampers inactivation of the hERG channels, and increases magnitude of the window current suggesting that the p.R397C is a gain-of-function mutation. In silico modeling demonstrated that this missense mutation potentially leads to the shortening of action potential in the heart.
KEY WORDS: Brugada syndrome, BrS, KCNH2, Kv11.1, IKr, patch-clamp, inherited channelopathy, Short QT syndrome, gain-of-function

DOI: 10.1134/S000629792403012X

Publisher’s Note. Pleiades Publishing remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.